Years After Legalization, Abortion Patients in Catalonia Still Face Delays

When Spain liberalized its abortion law in 2010, advocates described the reform as a watershed: abortion would no longer be a legal gray zone but a service guaranteed within the public health system, available on request and covered by public funding. More than a decade later, in the autonomous community of Catalunya, the promise of that reform is being tested against the everyday realities of patients trying to use it. A new ethnographic study, published in the journal Discover Social Science and Health, documents what actually happens when people navigate the Catalan public health system to obtain a publicly funded abortion, and its findings are sobering. Even in a setting with legal abortion, public financing, and an established service infrastructure, patients reported persistent delays, misinformation, and stigma that shaped their care from the first phone call to the procedure itself.

The study was conducted by Bayla Ostrach, a medical anthropologist and family medicine researcher at Boston University School of Medicine, who carried out fieldwork at the only clinic then contracted with the Catalan public health system to provide full-spectrum abortion care. That single-clinic arrangement is itself a telling detail. Although abortion is, by policy, available through the public system in Catalunya, the actual delivery of services depends on a small network of contracted providers, meaning that patients in much of the region must travel to one facility to exercise a right that the law nominally guarantees everywhere. Using opportunistic and convenience sampling, Ostrach documented patient experiences directly within this setting, capturing the practical texture of access in a way that surveys and administrative data cannot.

Ethnographic methods of this kind are particularly well suited to studying abortion access because the barriers patients encounter are rarely formal or visible in policy documents. A waiting list that adds two weeks, a phone line that is difficult to reach, a health worker who implies that a medication regimen is the only appropriate option, or a comment that carries judgment—these are the frictions that accumulate into delay, and delay is the single most consequential variable in abortion care, since gestational age limits determine whether a patient can be treated at all. By embedding observation in the clinic and talking with patients as they moved through the system, the study was able to record these frictions as they occurred, rather than reconstructing them retrospectively.

The results converge on a central conclusion: years after liberalization, delays and obstacles persisted throughout the public health system. Participants described waiting periods and scheduling difficulties that pushed their care later into pregnancy, misinformation about what services were available and how to obtain them, and the continuing weight of abortion stigma, which manifested both in interactions with the health system and in patients’ own accounts of their decisions. Stigma, in this context, is not merely an emotional burden; it operates as a structural barrier, discouraging patients from asking questions, delaying their presentation for care, and shaping how providers communicate about options.

One of the study’s most striking findings concerns the form that stigma took within the publicly funded pathway itself. Participants reported pressure to undergo pharmacologic abortion—that is, medication-based termination rather than an aspiration or procedural method. Medication abortion is safe, effective, and appropriate for many patients, and its availability is an unambiguous good. The concern raised by the study is different: when patients are steered toward one method regardless of their clinical circumstances, gestational age, or personal preference, the pressure itself becomes a form of obstruction. Method choice in abortion care should reflect informed patient preference within clinical guidelines, and reports of systematic steering suggest that the public system’s delivery model, whatever its logistical rationale, was not consistently centering patient autonomy.

The study also documented the socioeconomic motivations that participants described for seeking abortion, particularly in the context of existing child-rearing responsibilities. Many patients were already parents, and their decisions were framed explicitly around the material realities of raising children—income, housing, work schedules, and the absence of adequate support. This finding aligns with a long line of research showing that the most common reasons women give for seeking abortion are financial and caregiving constraints rather than health complications or fetal indications. It also underscores a point that abortion access researchers have made repeatedly: the people most affected by delays and obstacles in publicly funded systems are those with the fewest private alternatives, and the most marginalized patients bear the brunt of every added barrier.

That distributional point is central to the study’s significance. The abstract notes that delays and obstacles appear to especially impact the most marginalized, and the single-contractor structure of Catalan abortion provision illustrates why. A patient with a car, flexible employment, and private resources can absorb travel costs, take time off, and, if necessary, pay for private care. A patient working hourly shifts, caring for children, or lacking documentation or funds cannot. When the public pathway is slow or opaque, the system effectively sorts patients by their capacity to navigate it, converting administrative friction into inequity. In this sense, the Catalan case is a warning for any health system that treats legal availability as equivalent to realized access.

The research also carries methodological and ethical weight. The study protocol was reviewed by the human subjects research board at Boston University School of Medicine and, under United States federal research regulations codified at 45 CFR 46, was determined exempt from further review, while still being conducted in accordance with those federal guidelines; all participants provided informed consent. The research was unfunded, and the author declares no competing interests. The article is published open access under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license, and the version shared ahead of final publication is citable and carries a permanent digital object identifier, a practice that journals increasingly use to speed the dissemination of peer-reviewed findings.

For public health, the implications reach well beyond Catalunya. The global health community has long identified access to safe, high-quality abortion as a priority, and the study’s central lesson is that liberalization is a beginning, not an endpoint. A law changes what is permitted; a health system determines what is possible. Between the two lie waiting times, referral pathways, provider training, method availability, information quality, and the informal norms that shape clinical encounters. The Catalan experience shows that even where all of these operate within a framework of legality and public funding, they can still function as obstacles—and that closing the gap requires monitoring not just whether services exist, but how patients actually experience them.

The study’s conclusion is deliberately restrained but pointed: years after abortion liberalization, overall health system delays and obstacles persisted, even in an ostensibly ideal setting of legality and public funding. That phrase—ostensibly ideal—is the finding’s sharpest edge. If a wealthy European region with a universal health system, a liberalized law, and public financing still produces the delays, misinformation, and stigma documented here, then no jurisdiction can assume that legal reform alone delivers equitable access. What remains to be studied, and what the Catalan case now demands, is the systematic measurement of patient experience as a core indicator of abortion service quality, treated with the same seriousness as clinical outcomes. Until then, the gap between the law on the books and the care patients receive will continue to fall hardest on those with the least capacity to bridge it.

Subject of Research: Patient experiences navigating publicly funded abortion care in the Catalan public health system years after Spain's 2010 abortion liberalization

Article Title: Patient experiences in the Catalan public health system years after abortion liberalization

Article References: Ostrach, B. (2026). Patient experiences in the Catalan public health system years after abortion liberalization. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00486-4

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00486-4

Keywords: abortion access, abortion delays, abortion stigma, Catalonia, Catalunya, public health system, publicly funded healthcare, Spain abortion law, medication abortion, health equity, medical anthropology, reproductive health